Elliptic Laboratories ASA (OSL:ELABS)
Norway · Delayed Price · Currency is NOK 2.480
-0.020 (-0.80%)
Aug 4, 2026, 4:25 PM CET
Elliptic Laboratories ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 313 | 715 | 1,103 | 1,786 | 2,295 | 2,882 | |
Market Cap Growth | -75.37% | -35.20% | -38.24% | -22.15% | -20.36% | 2286.11% |
Enterprise Value | 253.67 | 684.95 | 1,046 | 1,697 | 2,129 | 2,681 |
Last Close Price | 2.48 | 6.79 | 10.48 | 17.04 | 22.05 | 27.75 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 131.00 | - | - | - |
Forward PE | - | 16.98 | 12.59 | 40.33 | 40.09 | - |
PS Ratio | 3.42 | 6.96 | 8.27 | 25.66 | 44.08 | 45.71 |
PB Ratio | 1.42 | 3.80 | 3.39 | 5.85 | 7.05 | 8.41 |
P/TBV Ratio | 1.80 | 6.13 | 4.50 | 7.12 | 8.24 | 8.91 |
P/FCF Ratio | - | 119.89 | - | - | - | - |
P/OCF Ratio | - | 119.27 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.77 | 6.67 | 7.85 | 24.37 | 40.90 | 42.52 |
EV/EBITDA Ratio | 113.40 | - | 39.38 | - | - | - |
EV/EBIT Ratio | - | - | 222.13 | - | - | - |
EV/FCF Ratio | - | 114.87 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.04 | 0.07 | 0.03 | 0.04 |
Debt / EBITDA Ratio | 6.43 | - | 0.73 | - | - | - |
Debt / FCF Ratio | - | 2.20 | - | - | - | - |
Net Debt / Equity Ratio | -0.27 | -0.16 | -0.17 | -0.29 | -0.51 | -0.59 |
Net Debt / EBITDA Ratio | -26.66 | 1.37 | -2.15 | 2.67 | 5.37 | 71.05 |
Net Debt / FCF Ratio | 2.52 | -5.02 | 5.38 | 1.95 | 9.55 | 18.57 |
Asset Turnover | 0.53 | 0.35 | 0.38 | 0.20 | 0.14 | 0.21 |
Quick Ratio | 6.68 | 5.21 | 7.83 | 7.45 | 13.13 | 14.67 |
Current Ratio | 6.68 | 5.21 | 7.83 | 7.45 | 13.13 | 14.67 |
Return on Equity (ROE) | -60.60% | -54.53% | 2.84% | -12.08% | -9.87% | -4.22% |
Return on Assets (ROA) | -38.51% | -37.80% | 0.70% | -11.60% | -9.82% | -3.23% |
Return on Invested Capital (ROIC) | -57.39% | -51.67% | 1.02% | -21.53% | -23.44% | -7.53% |
Return on Capital Employed (ROCE) | -11.83% | -17.75% | 1.43% | -15.22% | -12.29% | -3.99% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | - | - | 0.76% | - | - | - |
FCF Yield | - | 0.83% | - | - | - | - |
Buyback Yield / Dilution | -10.12% | 5.38% | -6.67% | -0.33% | -5.74% | -10.18% |
Total Shareholder Return | -10.12% | 5.38% | -6.67% | -0.33% | -5.74% | -10.18% |